At the time when endogenous insulin secretion can no longer counteract insulin resistance (at the debut of T2D) the net insulin action in the liver is lower and does not overall suppress MBL, although, within the group of T2D, there is still an increasing suppression of MBL with increasing fat percent and obesity. The gene discussed is MBL2; the disease is Obesity.